Commercialisation news

The latest commercialisation news from the ¾«¶«Ó°Òµ.

Off
Geoptic logo

Geoptic awarded prestigious King’s Award for Enterprise in Innovation

Geoptic has been awarded a King’s Award for Enterprise in the Innovation category — considered the highest official honours for UK businesses.

DNA strand

FDA approves trial to advance pioneering treatment for Hereditary Spastic Paraplegia (HSP)

The US Food and Drug Administation (FDA) has approved BlackfinBio Limited’s Phase 1/2 clinical trial for its novel adeno-associated virus (AAV) gene therapy targeting Hereditary Spastic Paraplegia (HSP) Type 47 (SPG47).
Researcher working in AMRC facility

Leading investors back Northern Gritstone with new £50 million fundraise

Northern Gritstone has announced its latest fundraise of £50 million from leading institutional investors bringing its total permanent capital to £362 million.

DNA strands

¾«¶«Ó°Òµspinout takes major step towards advancing pioneering treatments for Hereditary Spastic Paraplegia (HSP)

BlackfinBio Limited is a spinout company from the ¾«¶«Ó°Òµ set to pioneer novel therapies for rare genetic neurological diseases.

Nick Thompson, CEO of BOW, stood next to Daniel Camilleri, CTO and Founder of BOW with some robots in the background

¾«¶«Ó°Òµ spinout company receives £4 million investment to unleash full potential of robotics

A ¾«¶«Ó°Òµ spinout company that is set to help developers overcome the cost and complexity of programming robots, has secured £4 million in funding.
Exciting Instruments team

¾«¶«Ó°Òµ spinout secures £4m in seed funding round - technology set to support health-related research

A ¾«¶«Ó°Òµ spinout that has developed a single-molecule detection platform to support health research has raised £4m in funding.
Laboratory technician uses micro-pipette

City centre labs to drive innovation and start-up success

In a move set to propel innovation and growth of early-stage companies, ¾«¶«Ó°ÒµTechnology Parks (STP) and ¾«¶«Ó°Òµ are teaming up to build new lab spaces in the city centre.

An image of the Tasty Spoon concept, an arm of a woman is holding the spoon above a plate. The spoon is grey.

New ‘Tasty Spoon’™ will enhance food flavours for people living with dementia

A spoon, designed to enhance the flavour of food for dementia patients experiencing a loss of taste, could help combat high levels of malnutrition.
Group of people talking at an event

Northern universities launch spinout mentor network to empower entrepreneurs

The universities of Sheffield, Leeds, and Manchester are proud to announce the launch of the Northern Triangle Mentor Network, a dynamic initiative designed to propel commercialisation opportunities and empower early-stage spinouts.
Medical illustration of a brain with stroke symptoms

New company Midland Pharmaceuticals launched to develop therapeutics for stroke and spinal cord injury

Researchers from the ¾«¶«Ó°Òµ and the University of Birmingham have joined forces with NLC Health Ventures to co-found a company developing new treatments for spinal cord injuries and stroke.
DNA Molecule

¾«¶«Ó°Òµspinout company grows to lead on next generation biomedicines and bioprocesses

SynGenSys, a fast-growing biotechnology company spun out of the ¾«¶«Ó°Òµ, has announced the appointment of Dr. Andy Racher as its Commercial Operations Director.
A portrait photo of Professor James Marshall

World leading expert on bio-inspired AI to direct ¾«¶«Ó°Òµâ€™s Centre for Machine Intelligence

One of the world’s leading innovators in bio-inspired AI has joined the ¾«¶«Ó°Òµ, as part of a new multi-million pound centre that is set to transform the institution’s research, innovation and teaching around artificial intelligence.

Dr Tim Craggs with instrument

Northern Triangle Talent Project secures £1.5m funding to strengthen regional commercialisation activity

The Northern Triangle Talent Project has secured funding to strengthen the regional technology commercialisation ecosystem and attract top talent to the north of England.
DNA Molecule

¾«¶«Ó°Òµ spinout company to pioneer novel therapies for genetic neurological diseases

BlackfinBio has raised £2.75 million seed investment to advance revolutionary treatments for Hereditary Spastic Paraplegia (HSP).

The ¾«¶«Ó°Òµ's Diamond building seen in the ¾«¶«Ó°Òµskyline

The ¾«¶«Ó°Òµ's response to the independent review of university spin-out companies

The ¾«¶«Ó°Òµ welcomes the announcement of £20m to help universities develop more spinout companies made in the autumn statement, as well as the independent review of spin-out companies.
A close up of plastic pellets produced by Floreon

World’s first low-energy bioplastics developed with the ¾«¶«Ó°Òµ raises £2 million investment

The world’s first low-energy, non-oil-based, high-performance bioplastic, developed by Floreon with the ¾«¶«Ó°Òµ, has secured £2 million financing from Northern Gritstone.

Neuron cells system - 3d rendered image of Neuron cell network on black background

¾«¶«Ó°Òµ spinout company Crucible Therapeutics raises £5 million to advance pioneering treatments for neurological diseases

¾«¶«Ó°Òµ spinout company, Crucible Therapeutics, a biotechnology company developing novel therapies to treat the most common genetic form of MND and frontotemporal dementia (FTD), has secured £5 million from Northern Gritstone.
An aerial view of the ¾«¶«Ó°Òµ Innovation District featuring the Factory 2050 building

Investment zones are the key to taking our potential towards prosperity

Professor Koen Lamberts, President and Vice-Chancellor of the ¾«¶«Ó°Òµ, discusses how the new South Yorkshire Investment Zone can turn Yorkshire's potential into prosperity.

Inner ear

Unlocking the human inner ear for new therapies to improve hearing loss and deafness

An international team of scientists and surgeon has discovered a secure clinical pathway to the inner ear, which will enable the application of a range of regenerative therapies to restore hearing.

A blue sky above the University's Diamond building

Northern Gritstone secures first close of £215 million ahead of making its first investments

A new investment company founded by the universities of Sheffield, Leeds and Manchester to help boost the commercialisation of university spinouts and start-ups in the north of England has today (20 May 2022) announced a first close of £215 million.
Close up of ear

Rinri Therapeutics raises £10 million to advance stem cell therapy for hearing loss

¾«¶«Ó°Òµ spinout company, Rinri Therapeutics, has raised a total of £10 million from investors and the UK Future Fund to advance its novel stem cell therapy to restore hearing loss.

Abstract woman scientist illustration

¾«¶«Ó°Òµspin-out set up to facilitate life-science discoveries

Understanding how molecules interact within the body is essential in supporting the development of treatments and therapies. Exciting Instruments, a ¾«¶«Ó°Òµ spin-out company, is breaking down barriers for researchers in this field.
Thumbnail

Northern Gritstone announces leadership team

Northern Gritstone, a new investment company founded by the Universities of Leeds, Manchester and Sheffield, has appointed Lord Jim O’Neill as Non-Executive Chairman and Duncan Johnson as CEO.
Universities of Sheffield, Leeds and Manchester launch Northern Gritstone

Northern universities launch new investment company

The universities of Sheffield, Leeds and Manchester are launching a new investment company to help boost the commercialisation of university spinouts and start-ups in the North of England.